New Publication Delivers Inside Track on Centers for Medicare and Medicaid Services Device Reimbursement Rates
'Device Reimbursement Report Will Help Manufacturers Profit From
Complex CMS Rules,' FDAnews Publisher Cynthia Carter Says
FALLS CHURCH, Va., Feb. 7 /PRNewswire/ -- The leading provider of news and information on the U.S. Food and Drug Administration (FDA) today announced the launch of the only newsletter devoted to tracking and explaining rules, regulations, pending legislation and other issues affecting Medicare and Medicaid reimbursement for medical devices. The new biweekly newsletter, Device Reimbursement Report, gives medical device makers, hospital administrators, lobbyists and other decisionmakers advance news and analysis of federal legislation affecting Medicare and reimbursement issues; up-to-date information on actions, rulings and timetables coming out of the Centers for Medicare and Medicaid Services (CMS); and inside looks at lobbying efforts of interested parties. "Device Reimbursement Report satisfies a major information need among buyers, users and manufacturers of medical devices," said Cynthia Carter, publisher of FDAnews. "More than ever before, providers need to know which devices will get higher reimbursement rates, which ones will be reclassified with lower rates and how different settings and uses can affect those rates of reimbursement -- and ultimately their bottom lines." On Nov. 29, 2001, the CMS released new rules for hospital Outpatient Prospective Payment Systems (OPPS), shifting to new methods of reimbursement for more than 1,100 high-tech medical procedures. "Reimbursement reform is one of the most far-reaching issues affecting medical devices today," said Richard Crider, editor of Device Reimbursement Report. "Advance warning of what CMS will reimburse -- and what it will not -- will be the key to profits for both healthcare institutions and manufacturers in the months and years to come." Device Reimbursement Report also tracks changes and updates in Ambulatory Payment Classifications (APCs), as well as APC applications and appeals for reclassification; and provides its readers with essential details gleaned from Federal Register notices and CMS memoranda. Device Reimbursement Report, published 24 times a year, is available in print and electronic formats for $827/year. ABOUT FDANEWS FDAnews is the premier provider of domestic and international regulatory, legislative and business news and information for executives in industries regulated by the U.S. Food and Drug Administration and the European Commission. FDAnews also publishes Devices & Diagnostics Letter, The GMP Letter, Part 11 Compliance Report and many other information resources to help medical device and pharmaceutical executives meet their business and regulatory challenges. Since 1972, the seasoned staff of FDAnews journalists has been dedicated to providing executives in the regulated community with timely, insightful and practical news and analysis on mission critical issues, key industry developments and regulatory, legislative and policy initiatives. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books, special reports, European documents and conferences to keep abreast of international standards, stay in compliance with the FDA's complex and ever-changing regulations, get their products to market faster and boost profits. MAKE YOUR OPINION COUNT - Click Here http://tbutton.prnewswire.com/prn/11690X17744515
More by this Source
FDAnews Announces Social Media Strategies for Drug & Device Companies Virtual Conference
May 14, 2013, 13:41 ET
FDAnews Announces Medical Device Risk Management Conference, July 11-12, 2013, Boston, MA
Apr 26, 2013, 12:52 ET
Pharma Quality Assurance: FDA Compliance Solutions for Pharma Quality Managers
Apr 25, 2013, 06:43 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.